Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frovatriptan for prevention of menstrually associated migraine
NCT01035983Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Dec 2003
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of frovatriptan in menstrual migraine, sponsored by Endo International plc. Started Dec 2003; status: completed.
02
Drugs
frovatriptan
03
Conditions
menstrual migraine
Beyond the preview
Go deeper on NCT01035983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01035983.